Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Munch

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|June 24, 1998
Epstein-Barr virus strain characterizationM Munch
Journal of Neurovirology|June 29, 2000
The association between multiple sclerosis and infection with Epstein-Barr virus and retrovirusS Haahr, M Munch
Epidemiology (Cambridge, Mass.)|October 6, 2000
Epstein-Barr virus and multiple sclerosisA Ascherio, M Munch
Ugeskrift for Laeger|July 31, 1995
[Paraquat poisoning. Treatment and prognosis]C B Thomsen, M Munch
Clinical and Experimental Dermatology|February 13, 2001
Treatment of perforating collagenosis of diabetes and renal failure with allopurinolM Munch, E Balslev, G B Jemec
Clinical Molecular Pathology|October 1, 1996
Mutations in the Epstein-Barr virus latent membrane protein-1 (BNLF-1) gene in spontaneous lymphoblastoid cell lines: effect on in vitro transformation associated parameters and tumorigenicity in SCID and nude miceK Sandvej, M Munch, S Hamilton-Dutoit
Biochimica Et Biophysica Acta|September 3, 1993
Interconversions between active, inert and substrate forms of denatured/refolded type-1 plasminogen activator inhibitorM Munch, C W Heegaard, P A Andreasen
Ugeskrift for Laeger|November 5, 1990
[Treatment of severe primary hypercholesterolemia with lovastatin (Mevacor). A new therapeutic principle]A Leth, M Munch, B Nielsen, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|December 31, 1997
[Changes among residents in homes for the aged in Bergen between 1985-96]H A Nygaard, M Naik, E Moen, et al.
FEBS Letters|December 16, 1991
Type-1 inhibitor of plasminogen activators. Distinction between latent, activated and reactive centre-cleaved forms with thermal stability and monoclonal antibodiesM Munch, C Heegaard, P H Jensen, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|June 24, 1998
Epstein-Barr virus strain characterizationM Munch
Journal of Neurovirology|June 29, 2000
The association between multiple sclerosis and infection with Epstein-Barr virus and retrovirusS Haahr, M Munch
Epidemiology (Cambridge, Mass.)|October 6, 2000
Epstein-Barr virus and multiple sclerosisA Ascherio, M Munch
Ugeskrift for Laeger|July 31, 1995
[Paraquat poisoning. Treatment and prognosis]C B Thomsen, M Munch
Clinical and Experimental Dermatology|February 13, 2001
Treatment of perforating collagenosis of diabetes and renal failure with allopurinolM Munch, E Balslev, G B Jemec
Clinical Molecular Pathology|October 1, 1996
Mutations in the Epstein-Barr virus latent membrane protein-1 (BNLF-1) gene in spontaneous lymphoblastoid cell lines: effect on in vitro transformation associated parameters and tumorigenicity in SCID and nude miceK Sandvej, M Munch, S Hamilton-Dutoit
Biochimica Et Biophysica Acta|September 3, 1993
Interconversions between active, inert and substrate forms of denatured/refolded type-1 plasminogen activator inhibitorM Munch, C W Heegaard, P A Andreasen
Ugeskrift for Laeger|November 5, 1990
[Treatment of severe primary hypercholesterolemia with lovastatin (Mevacor). A new therapeutic principle]A Leth, M Munch, B Nielsen, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|December 31, 1997
[Changes among residents in homes for the aged in Bergen between 1985-96]H A Nygaard, M Naik, E Moen, et al.
FEBS Letters|December 16, 1991
Type-1 inhibitor of plasminogen activators. Distinction between latent, activated and reactive centre-cleaved forms with thermal stability and monoclonal antibodiesM Munch, C Heegaard, P H Jensen, et al.
Pageof 5